BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anderson R, Feldman C. Pneumolysin as a potential therapeutic target in severe pneumococcal disease. J Infect 2017;74:527-44. [PMID: 28322888 DOI: 10.1016/j.jinf.2017.03.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kucinskaite-Kodze I, Simanavicius M, Dapkunas J, Pleckaityte M, Zvirbliene A. Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity. Biomolecules 2020;10:E1009. [PMID: 32650398 DOI: 10.3390/biom10071009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lv Q, Zhang P, Quan P, Cui M, Liu T, Yin Y, Chi G. Quercetin, a pneumolysin inhibitor, protects mice against Streptococcus pneumoniae infection. Microb Pathog 2020;140:103934. [PMID: 31862394 DOI: 10.1016/j.micpath.2019.103934] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
3 Aceil J, Avci FY. Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets. Front Cell Infect Microbiol 2022;12:832254. [DOI: 10.3389/fcimb.2022.832254] [Reference Citation Analysis]
4 Domon H, Isono T, Hiyoshi T, Tamura H, Sasagawa K, Maekawa T, Hirayama S, Yanagihara K, Terao Y. Clarithromycin Inhibits Pneumolysin Production via Downregulation of ply Gene Transcription despite Autolysis Activation. Microbiol Spectr 2021;9:e0031821. [PMID: 34468195 DOI: 10.1128/Spectrum.00318-21] [Reference Citation Analysis]
5 Maatsola S, Kurkinen S, Engström MT, Nyholm TKM, Pentikäinen O, Salminen JP, Haataja S. Inhibition of Pneumolysin Cytotoxicity by Hydrolysable Tannins. Antibiotics (Basel) 2020;9:E930. [PMID: 33371182 DOI: 10.3390/antibiotics9120930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Letsiou E, Teixeira Alves LG, Fatykhova D, Felten M, Mitchell TJ, Müller-Redetzky HC, Hocke AC, Witzenrath M. Microvesicles released from pneumolysin-stimulated lung epithelial cells carry mitochondrial cargo and suppress neutrophil oxidative burst. Sci Rep 2021;11:9529. [PMID: 33953279 DOI: 10.1038/s41598-021-88897-y] [Reference Citation Analysis]
7 Kammann T, Hoff J, Yildirim I, Shkodra B, Müller T, Weber C, Gräler MH, Maus UA, Paton JC, Singer M, Traeger A, Schubert US, Bauer M, Press AT. Intracellularly Released Cholesterol from Polymer-Based Delivery Systems Alters Cellular Responses to Pneumolysin and Promotes Cell Survival. Metabolites 2021;11:821. [PMID: 34940579 DOI: 10.3390/metabo11120821] [Reference Citation Analysis]
8 Feldman C, Normark S, Henriques‐normark B, Anderson R. Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community‐acquired pneumonia. J Intern Med 2019;285:635-52. [DOI: 10.1111/joim.12875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Panagiotou S, Chaguza C, Yahya R, Audshasai T, Baltazar M, Ressel L, Khandaker S, Alsahag M, Mitchell TJ, Prudhomme M, Kadioglu A, Yang M. Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity. Sci Rep 2020;10:17313. [PMID: 33057054 DOI: 10.1038/s41598-020-73454-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Anderson R, Feldman C. Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia. J Infect 2017;75:473-85. [PMID: 28943342 DOI: 10.1016/j.jinf.2017.09.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
11 Stevens EJ, Morse DJ, Bonini D, Duggan S, Brignoli T, Recker M, Lees JA, Croucher NJ, Bentley S, Wilson DJ, Earle SG, Dixon R, Nobbs A, Jenkinson H, van Opijnen T, Thibault D, Wilkinson OJ, Dillingham MS, Carlile S, McLoughlin RM, Massey RC. Targeted control of pneumolysin production by a mobile genetic element in Streptococcus pneumoniae. Microb Genom 2022;8. [PMID: 35416147 DOI: 10.1099/mgen.0.000784] [Reference Citation Analysis]
12 Grousd JA, Rich HE, Alcorn JF. Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia. Clin Microbiol Rev 2019;32:e00107-18. [PMID: 31142498 DOI: 10.1128/CMR.00107-18] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
13 Tuft S, Somerville TF, Li JO, Neal T, De S, Horsburgh MJ, Fothergill JL, Foulkes D, Kaye S. Bacterial keratitis: identifying the areas of clinical uncertainty. Prog Retin Eye Res 2021;:101031. [PMID: 34915112 DOI: 10.1016/j.preteyeres.2021.101031] [Reference Citation Analysis]
14 Pereira JM, Xu S, Leong JM, Sousa S. The Yin and Yang of Pneumolysin During Pneumococcal Infection. Front Immunol 2022;13:878244. [DOI: 10.3389/fimmu.2022.878244] [Reference Citation Analysis]
15 Han C, Zhang M. Genetic diversity and antigenicity analysis of Streptococcus pneumoniae pneumolysin isolated from children with pneumococcal infection. International Journal of Infectious Diseases 2019;86:57-64. [DOI: 10.1016/j.ijid.2019.06.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Wang Y, Xia L, Wang G, Lu H, Wang H, Luo S, Zhang T, Gao S, Huang J, Min X. Subcutaneous immunization with the fusion protein ΔA146Ply-SP0148 confers protection against Streptococcus pneumoniae infection. Microb Pathog 2021;162:105325. [PMID: 34848296 DOI: 10.1016/j.micpath.2021.105325] [Reference Citation Analysis]
17 Anderson R, Nel JG, Feldman C. Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia. Int J Mol Sci 2018;19:E1147. [PMID: 29641429 DOI: 10.3390/ijms19041147] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
18 Riegler AN, Mann B, Orihuela CJ, Tuomanen E. Opening the OPK Assay Gatekeeper: Harnessing Multi-Modal Protection by Pneumococcal Vaccines. Pathogens 2019;8:E203. [PMID: 31652741 DOI: 10.3390/pathogens8040203] [Reference Citation Analysis]
19 Letsiou E, Teixeira Alves LG, Felten M, Mitchell TJ, Müller-Redetzky HC, Dudek SM, Witzenrath M. Neutrophil-Derived Extracellular Vesicles Activate Platelets after Pneumolysin Exposure. Cells 2021;10:3581. [PMID: 34944089 DOI: 10.3390/cells10123581] [Reference Citation Analysis]
20 Cools F, Delputte P, Cos P. The search for novel treatment strategies for Streptococcus pneumoniae infections. FEMS Microbiol Rev 2021:fuaa072. [PMID: 33399826 DOI: 10.1093/femsre/fuaa072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]